In this study, we sought to characterize the clinical features, histopathology, and molecular typing of the prion protein (PrP) associated with 2-OPRI patients and to determine the risk for Creutzfeldt–Jakob disease (CJD) in carriers of the 2-OPRI variant. This evidence concerns the gene PRNP and Creutzfeldt Jacob disease.